Evolent Health (EVH) revenue breakdown
By segment, Clinical Solutions is the largest at 70% of fiscal 2022 revenue, growing 50% a year over 3 years.
By product, Performance Suite is the largest at 62% of fiscal 2023 revenue; Cases grew fastest, 478% a year over 2 years.
Revenue by segment
Fiscal years, as Evolent Health reports them in its 10-K filings; fiscal 2022 total $1.4B.
| Segments | 2018 | 2019 | 2020 | 2021 | 2022 | Share |
|---|---|---|---|---|---|---|
| Clinical Solutions | — | $278M | $542M | $598M | $945M | 70% |
| Evolent Health Services | — | $410M | $385M | $310M | $408M | 30% |
| Services | $547M | — | — | — | — | — |
| True Health | $95M | — | — | — | — | — |
Revenue by product
Fiscal years, as Evolent Health reports them in its 10-K filings; fiscal 2023 total $2.0B.
| Products | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | Share |
|---|---|---|---|---|---|---|---|---|---|
| Performance Suite | — | — | — | — | — | $551M | $809M | $1.2B | 62% |
| Specialty Technology and Services Suite | — | — | — | — | — | $43M | $52M | $296M | 15% |
| Administrative Services | — | — | — | — | — | $310M | $408M | $296M | 15% |
| Cases | — | — | — | — | — | $5M | $84M | $157M | 8% |
| Platforms And Operations Services | $216M | $405M | $500M | $672M | $913M | — | — | — | — |
| Premiums | — | — | $94M | — | — | — | — | — | — |
| Transformation Services | $38M | $29M | $33M | $15M | $12M | — | — | — | — |
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for EVH.
Open EVH in InvestinglyQuestions
Where does Evolent Health make its money?
In fiscal 2022, by segment: Clinical Solutions $945M, Evolent Health Services $408M.
From Evolent Health's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.